BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8964085)

  • 1. Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif.
    Felli MP; Moschella C; Farina AR; Alesse E; Screpanti I; Teti D; Frati L; Gulino A
    Cell Immunol; 1996 Sep; 172(2):229-34. PubMed ID: 8964085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
    Paliogianni F; Boumpas DT
    Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
    J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
    Cron RQ; Zhou B; Brunvand MW; Lewis DB
    Genes Immun; 2001 Dec; 2(8):464-8. PubMed ID: 11781715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octamer factors exert a dual effect on the IL-2 and IL-4 promoters.
    Pfeuffer I; Klein-Hessling S; Heinfling A; Chuvpilo S; Escher C; Brabletz T; Hentsch B; Schwarzenbach H; Matthias P; Serfling E
    J Immunol; 1994 Dec; 153(12):5572-85. PubMed ID: 7989759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells.
    Marti A; Jehn B; Costello E; Keon N; Ke G; Martin F; Jaggi R
    Oncogene; 1994 Apr; 9(4):1213-23. PubMed ID: 8134124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
    Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
    J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.
    de Grazia U; Felli MP; Vacca A; Farina AR; Maroder M; Cappabianca L; Meco D; Farina M; Screpanti I; Frati L; Gulino A
    J Exp Med; 1994 Oct; 180(4):1485-97. PubMed ID: 7931079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction and functional interference of C/EBPbeta with octamer factors in immunoglobulin gene transcription.
    Hatada EN; Chen-Kiang S; Scheidereit C
    Eur J Immunol; 2000 Jan; 30(1):174-84. PubMed ID: 10602039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element.
    Sterling K; Bresnick E
    Mol Pharmacol; 1996 Feb; 49(2):329-37. PubMed ID: 8632766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.
    Paliogianni F; Raptis A; Ahuja SS; Najjar SM; Boumpas DT
    J Clin Invest; 1993 Apr; 91(4):1481-9. PubMed ID: 8473495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides.
    Kaushansky K; Shoemaker SG; O'Rork CA; McCarty JM
    J Immunol; 1994 Feb; 152(4):1812-20. PubMed ID: 8120390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
    Fiala-Beer E; Lee AC; Murray M
    Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.
    Rosfjord E; Rizzino A
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1795-802. PubMed ID: 7945330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A B-cell coactivator of octamer-binding transcription factors.
    Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
    Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A-resistant transactivation of the IL-2 promoter requires activity of okadaic acid-sensitive serine/threonine phosphatases.
    Nebl G; Meuer SC; Samstag Y
    J Immunol; 1998 Aug; 161(4):1803-10. PubMed ID: 9712047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.